A
malaria
vaccine
that
prevents
infection
will
be
an
important
new
tool
in
continued
efforts
of
elimination,
and
such
vaccines
are
under
intense
development
for
the
major
human
parasite
Plasmodium
falciparum
(Pf).
Antibodies
elicited
by
can
block
initial
phases
when
sporozoites
deposited
into
skin
mosquito
bite
then
target
liver
further
development.
However,
there
currently
no
standardized
vivo
preclinical
models
measure
inhibitory
activity
antibody
specificities
against
Pf
sporozoite
via
bite.
Here,
we
use
liver-chimeric
mice
as
a
challenge
model
to
assess
prevention
natural
antibodies.
We
demonstrate
these
consistently
infected
with
this
combined
passive
transfer
either
monoclonal
antibodies
or
polyclonal
IgG
from
immune
serum
antibody-mediated
blocking
using
bioluminescent
imaging.
This
methodology
is
useful
down-select
functional
investigate
mechanisms
correlates
protection
clinical
trials,
thereby
informing
rational
optimization.
Infection and Immunity,
Год журнала:
2018,
Номер
86(7)
Опубликована: Май 4, 2018
ABSTRACT
Long-lasting
and
sterile
homologous
protection
against
malaria
can
be
achieved
by
the
exposure
of
malaria-naive
volunteers
under
chemoprophylaxis
to
Plasmodium
falciparum
-infected
mosquitoes
(chemoprophylaxis
sporozoite
[CPS]
immunization).
While
CPS-induced
antibodies
neutralize
infectivity
in
vitro
vivo
,
antibody-mediated
effector
mechanisms
are
still
poorly
understood.
Here,
we
investigated
whether
complement
contributes
preerythrocytic
immunity.
Sera
collected
before
after
CPS
immunization
presence
active
or
inactive
were
assessed
for
recognition
NF54
heterologous
NF135.C10
sporozoites,
fixation,
lysis,
possible
subsequent
effects
on
human
hepatocytes.
induced
sporozoite-specific
IgM
(
P
<
0.0001)
IgG
=
0.001)
with
complement-fixing
capacities
0.0001).
Sporozoite
lysis
0.017),
traversal
0.0001),
hepatocyte
invasion
inhibition
strongly
enhanced
complement.
Complement-mediated
negatively
correlated
cumulative
parasitemia
during
immunizations
0.013).
similarly
recognized
binding
sporozoites
was
reduced
0.023).
Although
did
not
differ
their
abilities
fix
complement,
lyse
inhibit
more
inhibited
0.008).
These
findings
demonstrate
that
have
activity,
thereby
significantly
further
enhancing
functional
.
The
combined
data
highlight
importance
as
an
additional
immune
mechanism
immunity
whole-parasite
malaria.
Biological reviews/Biological reviews of the Cambridge Philosophical Society,
Год журнала:
2019,
Номер
95(2), С. 305 - 332
Опубликована: Ноя. 7, 2019
ABSTRACT
Membrane
transport
proteins,
also
known
as
transporters,
control
the
movement
of
ions,
nutrients,
metabolites,
and
waste
products
across
membranes
a
cell
are
central
to
its
biology.
Proteins
this
type
serve
drug
targets
key
players
in
phenomenon
resistance.
The
malaria
parasite
has
relatively
reduced
transportome,
with
only
approximately
2.5%
genes
encoding
transporters.
Even
so,
assigning
functions
physiological
roles
these
ascertaining
their
contributions
action
resistance,
been
very
challenging.
This
review
presents
detailed
critique
synthesis
disruption
phenotypes,
protein
subcellular
localisations,
(observed
or
predicted),
links
antimalarial
resistance
for
each
parasite's
transporter
genes.
breadth
depth
gene
data
particularly
impressive,
at
least
one
phenotype
determined
asexual
blood
stage
gene,
multiple
phenotypes
available
76%
Analysis
curated
set
revealed
there
be
little
redundancy
Plasmodium
transportome;
almost
two‐thirds
essential
required
normal
growth
parasite,
proportion
increased
78%
when
other
life
stages
were
included
analysis.
These
observations,
together
finding
that
22%
transportome
is
implicated
existing
antimalarials
and/or
drugs
within
development
pipeline,
indicate
transporters
likely
serve,
already
serving,
targets.
Integration
different
biological
bioinformatic
sets
enabled
selection
candidates
processes
survival,
but
which
underlying
proteins
have
thus
far
remained
undiscovered.
include
potential
pantothenate,
isoleucine,
isopentenyl
diphosphate,
well
putative
anion‐selective
channels
may
pore
component
‘new
permeation
pathways’.
Other
novel
insights
into
biology
identification
treatments,
transmission‐blocking
drugs,
prophylactics,
genetically
attenuated
vaccines.
syntheses
presented
herein
foundation
elucidating
members
and,
ultimately,
explore
realise
therapeutic
Molecular Microbiology,
Год журнала:
2020,
Номер
115(5), С. 870 - 881
Опубликована: Ноя. 16, 2020
Abstract
Parasites
of
the
genus
Plasmodium
,
etiological
agent
malaria,
are
transmitted
through
bite
anopheline
mosquitoes,
which
deposit
sporozoites
into
host
skin.
Sporozoites
migrate
dermis,
enter
bloodstream,
and
rapidly
traffic
to
liver.
They
cross
liver
sinusoidal
barrier
traverse
several
hepatocytes
before
switching
productive
invasion
a
final
one
for
replication
inside
parasitophorous
vacuole.
Cell
traversal
functionally
independent
processes
that
require
proteins
secreted
from
specialized
secretory
organelles
known
as
micronemes.
In
this
review,
we
summarize
current
understanding
how
cells
productively
invade
hepatocytes,
discuss
role
environmental
sensing
in
migratory
an
invasive
state.
We
propose
timely
controlled
secretion
distinct
microneme
subsets
could
play
key
successful
migration
infection
hepatocytes.
A
better
these
essential
biological
features
sporozoite
may
contribute
development
new
strategies
fight
against
very
first
asymptomatic
stage
malaria.
Frontiers in Immunology,
Год журнала:
2017,
Номер
8
Опубликована: Фев. 13, 2017
Malaria
caused
by
Plasmodium
vivax
continues
being
one
of
the
most
important
infectious
diseases
around
world;
P.
is
second
prevalent
species
and
has
greatest
geographic
distribution.
Developing
an
effective
antimalarial
vaccine
considered
a
relevant
control
strategy
in
search
for
means
preventing
disease.
Studying
parasite
expressed
proteins
which
are
essential
host
cell
invasion
led
to
identifying
regions
recognised
individuals
who
naturally
exposed
infection.
Furthermore,
immunogenicity
studies
have
revealed
that
such
can
trigger
robust
immune
response
inhibit
sporozoite
(haepatic
stage)
or
merozoite
(erythrocyte
induce
protection.
This
review
provides
synthesis
date
concerning
antigenicity
both
synthetic
peptide
recombinant
protein
candidates
against
malaria
produced
vivax.
A
malaria
vaccine
that
prevents
infection
will
be
an
important
new
tool
in
continued
efforts
of
elimination,
and
such
vaccines
are
under
intense
development
for
the
major
human
parasite
Plasmodium
falciparum
(Pf).
Antibodies
elicited
by
can
block
initial
phases
when
sporozoites
deposited
into
skin
mosquito
bite
then
target
liver
further
development.
However,
there
currently
no
standardized
vivo
preclinical
models
measure
inhibitory
activity
antibody
specificities
against
Pf
sporozoite
via
bite.
Here,
we
use
liver-chimeric
mice
as
a
challenge
model
to
assess
prevention
natural
antibodies.
We
demonstrate
these
consistently
infected
with
this
combined
passive
transfer
either
monoclonal
antibodies
or
polyclonal
IgG
from
immune
serum
antibody-mediated
blocking
using
bioluminescent
imaging.
This
methodology
is
useful
down-select
functional
investigate
mechanisms
correlates
protection
clinical
trials,
thereby
informing
rational
optimization.